149 -10 (60) 2023 — Djurayeva E.R., Ganiyeva N.A. — DIAGNOSTIC ASPECTS OF RHEUMATOID ARTHRITIS IN PATIENTS WITH COVID-19

DIAGNOSTIC ASPECTS OF RHEUMATOID ARTHRITIS IN PATIENTS WITH COVID-19

Djurayeva E.R., Tashkent medical academy

Ganiyeva N.A. Tashkent medical academy

Resume

This article presents the clinical and laboratory features of rheumatoid arthritis in patients who underwent COVID-19. As a result of the study, it was revealed that in RA patients who underwent COVID-19, progression of the disease and a high degree of activity of the process were often noted, which was confirmed by an increase in the indicators of acute phase tests, and systemic damage to internal organs was associated. Although there is currently no evidence that patients with autoimmune disorders or those taking immunosuppressive drugs are at greater risk of contracting COVID infection, there remains a theoretical risk of increased complications in these patients if they become infected.

Keywords: rheumatoid arthritis, Сovid-19, coronavirus

First page

863

Last page

865

For citation: Djurayeva E.R., Ganiyeva N.A. – DIAGNOSTIC ASPECTS OF RHEUMATOID ARTHRITIS IN PATIENTS WITH COVID-19 //New Day in Medicine 2023 10(60): 863-865 https://newdaymedicine.com/index.php/2023/12/27/l-708/

LIST OF REFERENCES:

  1. Белов Б.С., Каратеев А.Е. COVID-19: новый вызов ревматологам // Современная ревматология. 2020;14(2):110-116. DOI: 10.14412/1996-7012-2020-2-110-116.
  2. Насонов Е.Л. Коронавирусная болезнь 2019 (COVID-19): размышления ревматолога // Научно-практическая ревматология. 2020;58(2):123-132.
  3. Олюнин ЮА. Ревматоидный артрит. Основной симптом и симптоматическая терапия // Современная ревматология. 2014;4:54-59.
  4. Ganiyeva N.A., Djurayeva E.R., Abduazizova N.X., Aripova N.A., Kasimova M.B., Axmedova N.A., Bekenova G.T. Assessment of clinical and diagnostic aspects of atherosclerosis in patients with systemic scleroderma // Journal of Hunan University Natural Science. 2023;50(7):37-47.
  5. Gianfrancesco M., Hyrich K.L., Al-Adely S. et al. COVID-19 Global Rheumatology Alliance. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry // Ann Rheum Dis. 2020;79(7):859-866. DOI: 10.1136/annrheumdis-2020-217871.
  6. Hyrich K.L., Machado P.M. Rheumatic disease and COVID-19: epidemiology and outcomes // Nat Rev Rheumatol. 2021;17(2):71-82. DOI:10.1038/s41584-020-00562-2.
  7. Isaacs J.D., Burmester G.R. Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs // Ann Rheum Dis. 2020;79(8):991-993. DOI:10.1136/annrheumdis-2020-218019.
  8. Liu Y., Sawalha A.H., Lu Q. COVID-19 and autoimmune diseases // Curr Opin Rheumatol. – 2021;33(2):155-162. DOI:10.1097/BOR.0000000000000776.
  9. World Health Organization (WHO) Coronavirus disease (COVID-19) pandemic. Available at: https://www.who.int/emergencies/diseases/novel  coronavirus-2019. Accessed: 02.11.2020.

file

download